Parexel

Waltham, United States Founded: 1983 • Age: 43 yrs Acquired By EQT
Full-service clinical research organization services are provided globally by Parexel.
Request Access

About Parexel

Parexel is a company based in Waltham (United States) founded in 1983 was acquired by EQT in July 2021.. Parexel has completed 13 acquisitions, including 3ClinicalResearch, Atlas Medical Services and California Clinical Trials. Parexel operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and PRA Health Sciences, among others.

  • Headquarter Waltham, United States
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    EQT

    & 2 more

  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    EQT

    & 1 more

    (Jul 02, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Parexel
Headcount 10000+
Employee Profiles 768
Employee Profiles
People
Benjamin Pham
Clinical Research Associate
People
Martina Smith
Senior Finance Manager
People
Anastasia-Miruna Dan
Senior Medical Writer
People
Noelia Javega
Senior Director, Project Leadership

Unlock access to complete

Funding Insights of Parexel

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Parexel

Parexel has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include EQT, Goldman Sachs Asset Management and Pamplona Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
EQT is recognized as a global investment organization focused on value creation.
Founded Year Domain Location
Private equity investment firm focused on multiple sectors
Founded Year Domain Location
Global asset management and investment solutions are provided.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Parexel

Parexel has strategically engaged in corporate development activities, having acquired 13 companies. Notable acquisitions include 3ClinicalResearch, Atlas Medical Services and California Clinical Trials. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Cloud-based patient population and health management is offered to providers.
2011
Specialized CRO services are provided to pharma and biotech companies.
2009
Clinical randomization and trial supply management services are provided.
2008
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Parexel

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Parexel Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Parexel

Parexel operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and PRA Health Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapies for cancer and inflammatory diseases are developed.
domain founded_year HQ Location
CRO clinical development services are provided by Syneos Health.
domain founded_year HQ Location
Full-service CRO expertise in influenza and oncology research is offered.
domain founded_year HQ Location
Outsourced contract research organization services are provided to clients.
domain founded_year HQ Location
Global full-service CRO services are delivered in over 80 countries.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Parexel

Frequently Asked Questions about Parexel

When was Parexel founded?

Parexel was founded in 1983.

Where is Parexel located?

Parexel is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.

Who is the current CEO of Parexel?

Peyton Howell is the current CEO of Parexel.

What does Parexel do?

Parexel International was founded in 1983 and is headquartered in Waltham, United States. Operations are conducted as a clinical research organization in the biopharmaceutical sector, with services encompassing clinical trials across phases I-IV, consulting on regulatory compliance and product development, informatics for data management, and access solutions for market entry and drug safety. Presence is maintained in 51 countries, supporting development of pharmaceuticals, biologics, medical devices, and biosimilars.

Who are the top competitors of Parexel?

Parexel's top competitors include Emmes, Syneos Health and ClinChoice.

How many acquisitions has Parexel made?

Parexel has made 13 acquisitions, including 3ClinicalResearch, Atlas Medical Services, and California Clinical Trials.

Who are Parexel's investors?

Parexel has 3 investors. Key investors include EQT, Goldman Sachs Asset Management, and Pamplona Capital Management.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available